Research

The EC Approves Nivolumab Plus Chemotherapy as First Line Treatment for Oesophageal Cancer
Trastuzumab Deruxtecan Approved as Second-line Treatment in Europe For Patients With HER2-positive Advanced Gastric Cancer

On December 19th the European Commission (EC) approved the use of trastuzumab deruxtecan (Enhertu ®) plus chemotherapy (gemcitabine plus cisplatin...

Read

National Cancer Center Japan Asks for Your Support on a Project to Impact Patient Engagement

Would you like to know how and where patient engagement is happening in R&D? Would you like to see an objective comparison between Europe and J...

Read

COVID-19 impact on healthcare management of people with chronic diseases

The European Patients’ Forum (EPF) conducted a COVID-19 survey between 18 September to 18 October 2020 (the report is available here).&...

Read

Ensuring the Patient Voice in Research - Irish Initiative Shows the Way
Oncology Nurse Practitioner Looking for Help from Those with Higher Cancer Risk

Oncology nurse practitioner, research assistant and Education Working Group co-Chair of the European Oncology Nursing Society (EONS), Celia Díez ...

Read

Filter news
Categories
Annual General Meeting Beat Cancer Plan Beating Cancer Plan Biomarkers biosimilars Cancer Mission carers Carers Portal Clinical Trials colorectal cancer COR2ED COVID-19 DiCE DiCE Masterclass Dice members DiCE Survey drugs ECCAM ESMO GI EU4Health EU Commission EU Health Policy Platform EU Policy European Cancer Organisation events Gastric cancer health tips liver cancer mCRC medical education medical news metastatic colorectal cancer oesophageal cancer pancreatic cancer Partners patient education patient stories rare cancers research screening statistics Testing Thematic Network treatment wolfram nolte memorial award

In order to facilitate the use of our website, we use cookies.

Please confirm if you accept our tracking cookies. When declining the cookies, you can continue visiting the website without sending data to third party services. Read our complete cookie statement here.